SPHK1 and malignant mesothelioma: To test our hypothesis that SphK1 is an effective novel therapeutic target in malignant mesothelioma, we investigated multi walled nanotubes (MWNT)-induced granulamatous inflammation in control and SphK1−/− mice [33].